Contracts › 75A50122C00070

75A50122C00070: The Overall Objective of This Contract Is to Develop and Commercialize a Rapid Phenotypic Antimicrobial Susceptibility Testing (AST) System That Will Deliver Results for Definitive Therapeutic Decisions Within 4 to 6 Hours From Colonies on a Culture

Awarded to Beckman Coulter, Inc by Office of Assistant Secretary for Preparedness and Response.

$36.7Mobligated

$65.2Mpotential value

29 September 2026current end date

See modifications, all subcontractors and funding in FedSift →

Contract	75A50122C00070
Awardee	Beckman Coulter, Inc
Awarding agency	Office of Assistant Secretary for Preparedness and Response
Awarding office	BARDA - ASPR / DAAPPO / BARDA DCMA
NAICS	541714 Research and Development in Biotechnology (Except Nanobiotechnology)
PSC	AN13 Health R&D Services; Health Care Services; Experimental Development
Place of performance	CA
Offers received	1
Period of performance	30 September 2022 to 29 September 2026
Potential end	20 May 2028

Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.